High Tech Pharm Gelecekteki Büyüme

Future kriter kontrolleri 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for High Tech Pharm.

Anahtar bilgiler

n/a

Kazanç büyüme oranı

n/a

EPS büyüme oranı

Pharmaceuticals kazanç büyümesi	38.2%
Gelir büyüme oranı	n/a
Gelecekteki özkaynak getirisi	n/a
Analist kapsamı	None
Son güncelleme	n/a

Gelecekteki son büyüme güncellemeleri

Güncelleme yok

Recent updates

A Look At The Intrinsic Value Of High Tech Pharm Co., Ltd. (KOSDAQ:106190)

Oct 23

Is High Tech Pharm (KOSDAQ:106190) Using Too Much Debt?

Aug 06

Subdued Growth No Barrier To High Tech Pharm Co., Ltd. (KOSDAQ:106190) With Shares Advancing 25%

Jul 02

There's Reason For Concern Over High Tech Pharm Co., Ltd.'s (KOSDAQ:106190) Massive 25% Price Jump

May 09

What Is The Ownership Structure Like For High Tech Pharm Co., Ltd. (KOSDAQ:106190)?

Dec 15

Bu bölümde, yatırımcıların şirketin kâr elde etme kabiliyetini anlamalarına yardımcı olmak için genellikle profesyonel analistlerin fikir birliği tahminlerine dayanan gelir ve kazanç büyüme tahminlerini sunuyoruz. Ancak High Tech Pharm yeterli geçmiş veri sağlamadığından ve analist tahmini olmadığından, gelecekteki kazançları geçmiş verileri ekstrapole ederek veya analist tahminlerini kullanarak güvenilir bir şekilde hesaplanamaz.

SimplyWall St tarafından kapsanan şirketlerin %97'si geçmiş finansal verilere sahip olduğu için bu oldukça nadir bir durumdur.

Kazanç ve Gelir Büyüme Tahminleri

KOSDAQ:A106190 - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (KRW Millions )
Tarih	Gelir	Kazançlar	Serbest Nakit Akışı	Faaliyetlerden Nakit	Avg. Analist Sayısı
6/30/2024	83,502	13,522	3,075	6,791	N/A
3/31/2024	82,545	11,596	8,871	13,678	N/A
12/31/2023	76,772	8,076	-2,183	2,909	N/A
9/30/2023	79,175	8,114	43	4,862	N/A
6/30/2023	94,102	7,931	3,207	6,159	N/A
3/31/2023	102,150	6,799	2,574	4,034	N/A
12/31/2022	102,947	5,873	-4,359	-3,703	N/A
9/30/2022	88,688	5	2,500	2,834	N/A
6/30/2022	70,212	-1,205	-5,808	-5,020	N/A
3/31/2022	67,869	-2,977	-3,475	-2,615	N/A
12/31/2021	73,287	-1,225	6,068	6,928	N/A
9/30/2021	79,120	-1,054	-6,260	-5,124	N/A
6/30/2021	85,343	-367	-3,739	-3,289	N/A
3/31/2021	79,496	-2,535	-5,737	-4,921	N/A
12/31/2020	74,462	-3,152	-8,628	-7,691	N/A
9/30/2020	72,142	-5,630	-5,701	-4,966	N/A
6/30/2020	73,147	-7,340	-588	131	N/A
3/31/2020	67,977	-4,743	-2,416	-1,292	N/A
12/31/2019	63,068	-4,218	327	2,484	N/A
9/30/2019	61,495	-917	-5,540	-3,199	N/A
6/30/2019	54,381	1,116	-5,468	509	N/A
3/31/2019	60,013	2,413	-4,231	3,574	N/A
12/31/2018	66,388	2,608	-3,583	5,379	N/A
9/30/2018	69,853	2,711	-304	10,853	N/A
6/30/2018	70,430	2,863	-351	9,507	N/A
3/31/2018	67,593	2,640	N/A	10,103	N/A
12/31/2017	66,050	2,100	N/A	5,452	N/A
9/30/2017	65,534	4,866	N/A	3,572	N/A
6/30/2017	58,847	3,514	N/A	-95	N/A
3/31/2017	54,081	4,449	N/A	-366	N/A
12/31/2016	54,836	5,280	N/A	1,448	N/A
9/30/2016	50,660	3,024	N/A	3,178	N/A
6/30/2016	53,373	5,400	N/A	4,446	N/A
3/31/2016	53,452	6,263	N/A	7,419	N/A
12/31/2015	48,092	6,544	N/A	12,709	N/A
9/30/2015	47,604	8,613	N/A	13,701	N/A
6/30/2015	45,844	9,079	N/A	17,227	N/A
3/31/2015	49,264	7,038	N/A	13,997	N/A
12/31/2014	56,897	7,835	N/A	10,173	N/A
9/30/2014	58,740	6,651	N/A	14,917	N/A
6/30/2014	64,722	5,597	N/A	9,618	N/A
3/31/2014	68,248	9,260	N/A	9,152	N/A
12/31/2013	65,183	10,455	N/A	6,408	N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: Insufficient data to determine if A106190's forecast earnings growth is above the savings rate (2.6%).

Kazançlar ve Piyasa: Insufficient data to determine if A106190's earnings are forecast to grow faster than the KR market

Yüksek Büyüme Kazançları: Insufficient data to determine if A106190's earnings are expected to grow significantly over the next 3 years.

Gelir ve Pazar: Insufficient data to determine if A106190's revenue is forecast to grow faster than the KR market.

Yüksek Büyüme Geliri: Insufficient data to determine if A106190's revenue is forecast to grow faster than 20% per year.

Hisse Başına Kazanç Büyüme Tahminleri

Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: Insufficient data to determine if A106190's Return on Equity is forecast to be high in 3 years time

High Tech Pharm Gelecekteki Büyüme

Future kriter kontrolleri 0/6

Anahtar bilgiler

Gelecekteki son büyüme güncellemeleri

Recent updates

A Look At The Intrinsic Value Of High Tech Pharm Co., Ltd. (KOSDAQ:106190)

Now 21% undervalued after recent price drop

Is High Tech Pharm (KOSDAQ:106190) Using Too Much Debt?

Subdued Growth No Barrier To High Tech Pharm Co., Ltd. (KOSDAQ:106190) With Shares Advancing 25%

Investor sentiment improves as stock rises 18%

New minor risk - Share price stability

Investor sentiment improves as stock rises 16%

There's Reason For Concern Over High Tech Pharm Co., Ltd.'s (KOSDAQ:106190) Massive 25% Price Jump

Investor sentiment improves as stock rises 15%

Is High Tech Pharm (KOSDAQ:106190) A Risky Investment?

Inaugural dividend of ₩70.00 per share

Investor sentiment improves as stock rises 15%

Upcoming dividend of ₩50.00 per share

No independent directors

No independent directors

Inaugural dividend of ₩50.00 per share

Third quarter 2021 earnings released: ₩8.00 loss per share (vs ₩89.00 profit in 3Q 2020)

First quarter 2021 earnings released: EPS ₩64.00 (vs ₩7.00 loss in 1Q 2020)

We Think High Tech Pharm (KOSDAQ:106190) Has A Fair Chunk Of Debt

Did High Tech Pharm's (KOSDAQ:106190) Share Price Deserve to Gain 91%?

New 90-day high: ₩26,350

New 90-day high: ₩20,150

What Is The Ownership Structure Like For High Tech Pharm Co., Ltd. (KOSDAQ:106190)?

New 90-day high: ₩15,200

Third quarter 2020 earnings released: EPS ₩89.00

New 90-day high - ₩14,200

New 90-day high - ₩12,100

New 90-day high - ₩11,400

Kazanç ve Gelir Büyüme Tahminleri

Analist Gelecek Büyüme Tahminleri

Hisse Başına Kazanç Büyüme Tahminleri

Gelecekteki Özkaynak Getirisi

Büyüyen şirketleri keşfedin